Two of Moderna’s COVID-19 vaccine booster shots under study induced an immune response against SARS-CoV-2 and variants first identified in South Africa and Brazil, the company announced Wednesday. A variant-specific booster shot resulted in higher levels of neutralizing antibodies against the concerning South African variant with fewer side effects than a third shot of the… Read More »
By MIKE MAGEE This week J&J gained FDA approval for their 1-shot COVID vaccine, leading optimists like Pfizer Board member, Scott Gottlieb, to predict that we will have 100 million shots out there by the end of April, and on-demand offerings for the general public. In the race toward herd immunity, we could easily ignore… Read More »
Moderna on Wednesday announced that the COVID-19 vaccine it recently developed to address a concerning new coronavirus variant first identified in South Africa is ready to be tested in humans in clinical trials. Moderna in a news release said that it has shipped the first batch of doses of the new jab to the National… Read More »